 [2, 3] 
. Exponentially growing evidence demonstrates that miRNAs play a versatile function in multiple biological and metabolic progresses although the functions are still unclear for a majority of identified miRNAs
. Recent 
Brief history, biogenesis and the regulated mechanism of miRNAs
The first miRNA (lin-4) was discovered by Ambros group at Harvard University (now at the Dartmouth Medical School) in 1993 [8] . The story begins with the identification of a mutation in the nematode Caenorhabditis elegans, which disrupted the phase change from larval to adult [9] . After more than 10 years of searching for a responsible protein, Lee and colleagues (1993) [8, 10] . However, the important function of miRNAs was not known until another miRNA (let- 7) was identified in a variety of organisms [11, 12] and an extensive class of similar small RNAs were discovered in C. elegans, Drosophila melanogaster and humans [13] [14] [15] . Since then, miRNA-related research has become one of the hottest research topics in biology and medicine. It appears that miRNAs, generally speaking, exist and function in every biological and metabolic progress in any eukaryotes; and more than 5000 miRNAs have been identified and deposited in the miRNA database [16, 17] .
miRNAs are one class of non-protein-coding small RNAs of [19] [20] [21] [22] [23] [24] nucleotides. miRNA can be encoded anywhere in the genome [18] . A majority (61%) of miRNA genes are located at an intronic region of a protein-coding genes; however, miRNA genes can also be located in regions of exons or intergenes [18] [12, 36] ; however, this is not universal characteristic for all miRNAs. There are also many species-specific miRNAs; (6) miRNA precursors have high minimal folding free energy index (MFEI) [37] . Two recent studies demonstrated that miRNA precursors have much lower MFEI than that of other RNAs [37, 38] [16, 17] ; although the first miRNA was identified in 1993 in C. elegans [8] , its function was not recognized until 2000s when an extensive number of miRNAs were identified from three different species (C. elegans, fruit fly and human) [11] [12] [13] [14] [15] . Currently, more than 400 miRNAs have been identified in human and computational programs have predicted that there are more than 1000 miRNA genes in the human genome [40] . (2) [43] . siRNAs perfectly bind to their targeted mRNAs and guide mRNA cleavage endonucleolytically by RISC [44] . In contrast, miRNAs bind, in most cases, with imperfect complementarity to their targeted mRNAs and guide mRNA translation repression [45, 46] [47] [48] [49] , which plays important role in animal development [50] [51] [52] [53] . The exact mechanism for miRNA-mediated translation repression is still unknown, and one possible mechanism is miRNA-RISC complex may inhibit the initiation and/or elongation of protein translation by interacting with a various translation factors, such as eIF4F [54] [55] [56] [57] [58] [2, 65, 66] . This characteristic has been employed to design different computational programs for predicting miRNAs and their targets in animals [65] [66] [67] [68] [69] .
Roles of miRNAs in human disease and miRNAs as a novel biomarker for cancer and disease diagnostics

More and more evidence indicates that miRNAs play an important role in many human diseases, ranging widely from cancers, HIV to metabolic diseases. This evidence includes, but not limited to, (1) a unique set of miRNAs exists in a specific disease; (2) a unique expression of miRNAs in a certain human disease and (3) aberrant expression of miRNAs in human disease.
Cancers
The first evidence that miRNAs is related to cancers came from Croce group. In their study, they found two miRNA genes (miR-15 and miR-16) [82] . Another study demonstrated that islet-specific miR-375 regulated glucose-dependent insulin secretion [83] . In this study, Poy and colleague (2004) [84, 86, 87] . miRNAs also participate amino acid metabolism. In a bioinformatics paper, Stark and colleagues predicted that several amino-acid-metabolism-related enzymes are targeted by several miRNAs [88] . A followed study demonstrated that miR-29b controls the amount of branched chain (␣-ketoacid dehydrogenase complex [89] , which play an important role in the first irreversible step in branched-chain amino acid synthesis. As we know, several human metabolic diseases are related to a specific amino acid synthesis, this suggests that a specific miRNA may become a therapeutic target for amino-acid-related metabolic disease.
Virus infection
It is well known that plants and some animals employ the RNA interference (RNAi) pathway to against viral infection [90] . Several recent investigations demonstrated that miRNAs, with a similar gene regulation mechanism to RNAi, also play an important role in both animal and plant response to viral infection [91] [92] [93] [94] [38, [95] [96] [97] [98] [99] [42] . [91] .
. Many miRNAs have also identified in several viruses, including HIV, Epstein Barr virus (EBV) and human cytomegalovirus (HCMV), by computational and experimental methods
Currently, the molecular mechanism that miR-122 regulate HCV replication is still unclear. However, due to this phenomena and the fact those current therapies against HCV are frequently ineffective, miR-122 may present a novel alternative target for antiviral intervention and also provide a possible antiviral tool against a rapidly evolving viral genome. Host miRNAs also can target a specific virus RNA to restrict viral infection and protect cell itself. A recent study demonstrated that a cellular miRNA (miR-32) effectively restricts the accumulation of the retrovirus primate foamy virus type 1 (PFV-1) in human cells by targeting a PFV-1-encoding protein, Tas
In addition to the diseases reviewed above, miRNAs also regulate several other diseases (Table  2) . For example, miRNAs regulate brain and neuron development [102] [103] [104] ; aberrant expression of these miRNAs are associated with several neuronal diseases [105] , including Tourette's syndrome [106] , Alzheimer's disease [107] , schizophrenia and schizoaffective disorder [108] . [192] HCV infection miR-122↑ [101] PFV-1 infection miR-32↓ [91] Tourette's syndrome (TS) miR-189↑ [106] Parkinson's disease miR-133b↓ [193] Schizophrenia miR-130b [194] miRNAs as new targets for gene therapy [109] [110] [111] [112] [113] [114] . Takamizawa et al. (2004) found that let-7 was poorly expressed in lung cancers and reduced let-7 expression was significantly associated with shortened after operative survival independent of disease stage [114] [109, 111, 112, 114, 115] . Hmgo2 was found to be expressed in a wide variety of benign and malignant tumours [116] [117] [118] [119] [120] [121] [122] and overexpression of HMGA2 gene caused the onset of specific tumours [123] . miRNA let-7 regulates the HMGA2 gene expression by binding to seven conserved HMGA2 3' UTR complementary sites [2, 111] [124] [125] [126] . Recently, several investigations demonstrated that miRNAs play an important role in cardiac development and contractility, and several heart diseases are associated with the aberrant expression of certain miRNAs [124, [127] [128] [129] [130] [131] [132] [133] . Cardiac-specific overexpression of miR-1 inhibits cardiomyocyte in the embryonic heart [133] and exacerbated arrhythmogenesis [131] . In contrast, inhibiting miR-1 expression in infarcted rat hearts relieved arrhythmogenesis [131] . These suggest that miR-1 may have an important pathophysiological functions in heart failure and may serve as a potential antiarrhythmic target for gene therapy.
Several investigations demonstrated that let-7 expression level is associated with the pathogenesis of lung cancer and the expression of let-7 is significantly reduced in lung cancer tissues
. More interesting and importantly, an in vitro study show that transient overexpression of miRNA let-7 in the A549 lung adenocarcinoma cell lines inhibited lung cancer cell proliferation [114]. Recent studies indicate that let-7 inhibits tumour growth by targeting several oncogenes including RAS and highmobility group A2 (HMGA2)
Cardiac diseases Cardiac disease is one primary cause of morbidity and mortality in industrialized countries as well as the most frequent reason for non-infectious mortality in infants
Recent studies show that another miRNA, miR-133, was associated with cardiac hypertrophy [129, 132, 134, 135] . Overexpression of miR-133 inhibits hypertrophic symptom in both neonatal and adult mouse myocytes [132] . In contrast, down regulation of miR-133 enhances hypertrophic growth in mouse heart [132] . This suggests that miR-133 controls the pathogenesis of heart hypertrophy and overexpressing miR-133 in heart hypertrophic patients may serve as a novel gene therapy for preventing pathological cardiac hypertrophy. [137] . However, this study and a later study show that unmodified DNA oligonucleotides were not enough to inhibit miRNA activity [137, 138] [84, 85] .
Strategies for targeting miRNAs
Three successful modifications with addition of a chemical group to the 2'-hydroxyl group are 2'-Omethyl (2'-OMe), 2'-O-methoxyethyl (2'-MOE) and 2'-flouro (2'-F). 2'-OMe is one of the oldest, simplest
and most frequently used chemicals to modify oligonucleotides; in this modification, the methyl group enhance RNA resistance to nuclease cleavage and improve AMO-binding affinity to miRNAs [139] . Krutzfeldt [84] . Both studies found that silencing miR-122 with antisense AMO reduced plasma cholesterol levels [84, 85] . [139] [140] [141] . Due to its unprecedented affinity, good or even improved mismatch discrimination, low toxicity and increased metabolic stability, LNA has attracted the attention of scientists for in vivo applications of inhibition of miRNA activity [141] . In the past several years, LNA technology has been employed to detect miRNA function, to identify miRNA targets, and to inhibit miRNA activity by LNA-modified ASOs/AMOs [142] [143] [144] [145] [146] [147] [148] [149] . A recent study demonstrated that LNAmodified oligonucleotides (ASOs) stoichiometrically and reliably inhibited miRNAs with high specificity in a heterologous human embryonic kidney cell line HEK293 and in fruit fly cells [148] . A mixture of 2'-Omethyl-and LNA-modified ASOs was also employed to inhibit miR-21 expression for understanding the function of miRNAs in apoptosis progress in human glioblastoma cells [150] .
LNA-modified ASOs is structurally different from 2'-O-modifed ASOs. In LNA-modified ASOs, the 2'-oxygen is bridged to the 4'-postion of ribose via a methylene linker to form a rigid bicycle
To further investigate the potential application of ASOs and AMOs/antagomirs, the subcellular localization and effect factors on ASOs/AMOs have been studied. Davis and colleagues (2006) [151] . High activity of AMOs/antagomirs required an optimal number of phosphorothioate modifications and minimum length (>19 nt) [152] .
The above evidence suggests that ASOs/ AMOs/antagomirs may become a powerful tool to inhibit specific miRNA activity and a therapeutic strategy for miRNA therapy in a specific human disease, including cancers. [78, 79, 159] [84, 85] . However, Kutay and colleagues (2006) observed that reduced expression of miR-122 is associated with neoplastic transformation in rodent and human cells after a long-term treatment [163] . This suggests that more experiments should be performed before miRNA therapy can be tested in a clinical trial.
Delivering molecules to specific targeted sites
Concluding remarks and future perspectives
Potential effect of miRNAs on non-target genes
Many miRNAs have hundreds of conserved targets as well as additional non-conserved targets [12, 164, 165] Currently, more than 500 miRNAs are already found in human genome [17] and computational approach predicts that human may have more than 1000 miRNAs [40] . Computational analysis also demonstrated that more than 30% of protein-coding genes are regulated by at least one miRNAs at the post transcriptional level [2, 3] 
